BPA - VIDAS Kube Systems
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring VIDAS Kube Systems through a Blanket Purchase Agreement (BPA) to replace existing systems across all seven microbiology laboratories, as the vendor is discontinuing manufacturing and service support. These instruments serve as the primary equipment for pathogen screening in FDA laboratories, making their replacement a critical operational requirement. The solicitation is estimated to release on December 1, 2025, with an anticipated award date of May 1, 2026.
The contract is valued between $3,000,000 and $7,000,000 and will include a base order plus four option year units to be distributed across the seven microbiology laboratories. The procurement falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with no small business set-aside. Interested vendors should direct inquiries to the Food and Drug Administration's Acquisition Liaison at hfpacquisitions@fda.hhs.gov.
Forecast text
BPA - VIDAS Kube Systems
Base + 4 OY
Units are required in all 7 microbiology laboratories to replace existing VIDAS systems since the vendor will be discontinuing their service and manufacture. These are the primary instruments for pathogen screening in the labs.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast